1. Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial. Issue 1 (January 2023) Authors: Herrera, Alex F; Chen, Lu; Nieto, Yago; Holmberg, Leona; Johnston, Patrick; Mei, Matthew; Popplewell, Leslie; Armenian, Saro; Cao, Thai; Farol, Leonardo; Sahebi, Firoozeh; Spielberger, Ricardo; Chen, Robert; Nademanee, Auayporn; Puverel, Sandrine; Nwangwu, Mary; Lee, Peter; Song, Joo; Skarbnik, A... Journal: Lancet Issue: Volume 10:Issue 1(2023) Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗